Delivery Order SPE2DB22D9244-SPE2DB24FZS30

Award Date 7/12/24
Potential Completion Date 8/2/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.00 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4566087887 MIRENA 52 MG SYSTEMS. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 with DMS Pharmaceutical Group that runs through December 31, 2025. The IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,840.00 contract is for the delivery of Mirena 52 mg systems, a contraceptive product, to support the recurring medical supply needs of military health facilities. The award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $5,920.00 contract is for the delivery of the contraceptive device MIRENA 52 MG SYSTEMS to fulfill the recurring pharmaceutical needs of military health facilities supported by DLA. The award is not associated with any set-aside designation. DMS Pharmaceutical Group holds an indefinite delivery contract with DLA, valued up to...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The contract, valued at $11,840.00, is for the supply of 4566120513 MIRENA 52 MG SYSTEMS. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide the MIRENA 52 MG SYSTEMS pharmaceutical product. The $11,840.00 firm fixed-price contract has a period of performance through May 31, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which allows the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $7,104.00 order is for the supply of MIRENA 52 MG SYSTEMS, a contraceptive product, with a period of performance through October 15, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm...
This is a $7,104 firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The order is for the provision of Mirena 52 mg intrauterine contraceptive systems to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $3,552.00 contract is for the delivery of MIRENA 52 MG SYSTEMS, a type of contraceptive implant, with an ultimate completion date of September 26, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, holding a $499,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $81,339.84, is for the supply of MIRENA 52 MG SYSTEMS, a contraceptive device, to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under contract SPE2DB24FSY13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,104.00 award is for the delivery of Mirena 52 mg Systems, a contraceptive product, to support the medical supply needs of the Department of Defense (DoD). This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS...
  • SPE2DB22D9244
    Indefinite Delivery Contract
  • SPE2DB22D9244-SPE2DB24FZS30
    Delivery Order

This is a $11,840.00 firm-fixed-price delivery order awarded to DMS Pharmaceutical Group, Inc., a woman-owned small business, by the Defense Logistics Agency (DLA) under the DLA's SPE2DB procurement vehicle. The contract is for the delivery of MIRENA 52 MG SYSTEMS, a contraceptive product, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group is an experienced pharmaceutical wholesaler that provides a wide range of branded and generic prescription drugs, over-the-counter medications, and medical consumables to various government agencies, including the Department of Defense (DoD) and Department of Veterans Affairs (VA). This contract award has no set-aside designation and is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, to supply a comprehensive range of pharmaceutical items to military healthcare facilities.

Generated 10/11/24, 9:11 AM